You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered to your inbox every Tuesday and Thursday.
Lilly appoints chief AI officer
Drug giant Elie Lilly announcement Thomas Fuchs as the first head of AI. Fuchs was previously director of Hasso Plattner Institute for Digital Health has Mount Sinai in New York where he helped lead work on computational pathology. He is also the founder of several companies, including a startup specializing in cancer diagnosis. Paige AI.
Earlier this week we wrote about Eli Lilly’s latest AI drug development deal.
This article is reserved for STAT+ subscribers
Unlock this article, plus in-depth analysis, newsletters, premium events and news alerts.
Already have an account? Log in
